Results 41 to 50 of about 2,761 (203)

Concurrent analysis of Simvastatin and citicoline using a Reversed-phase High Performance Liquid Chromatography-Ultra Violet Method [PDF]

Trends in Pharmaceutical Sciences, 2019
To develop and evaluate a sensitive, accurate, rapid and reproducible high performance liquid chromatography analytical method for concurrent assay of simvastatin, a hyperlipidemia controlling agent, and citicoline, a psychostimulant agent, a C18 column (
Negin Mozafari, Soha Azadi, Soliman Mohammadi Samani, Fatemeh Farjadian, Amir Azadi   +4 more
doaj   +1 more source

Mild cognitive impairment treatment issues

Неврология, нейропсихиатрия, психосоматика, 2022
The development of dementia is preceded by mild cognitive impairment (MCI), the treatment of which can slow down the transformation of MCI into dementia. The article discusses drug and non-drug therapies for MCI.
L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich   +6 more
doaj   +1 more source

Citicoline on the Barthel Index

Indian Journal of Pharmacology, 2023
INTRODUCTION: Traumatic brain injury (TBI) is a paramount factor in mortality and morbidity. The clinical trials conducted to investigate the efficacy of neuroprotective agents, such as citicoline, as a therapeutic alternative for TBI have presented divergent findings.
Mahmoodkhani, Mehdi, Aminmansour, Bahram, Shafiei, Mehdi, Hasas, Mohammadreza, Tehrani, Donya Sheibani   +4 more
openaire   +2 more sources

Human vitreous concentrations of citicoline following topical application of citicoline 2% ophthalmic solution - Fig 2

, 2019
(A-B). Vitreous concentration of citicoline and metabolites. Citicoline and metabolites presence in human vitreous from control eyes (n = 5) and citicoline 2% treated eyes (n = 21).
Andrea Cacciamani (7866326), Romeo Altafini (7866329), Lucia Tanga (786589), Gianluca Manni (781382), Gloria Roberti (815919), Ivano Riva (4540321), Carmela Carnevale (6280860), Alessandra Micera (294762), Luca Bruno (7866323), Luciano Quaranta (3625409), Francesco Oddone (786588), Luca Agnifili (3625406)   +11 more
core   +1 more source

Citicoline in stroke and TBI clinical trials [PDF]

Nature Reviews Neurology, 2013
The results of recent citicoline trials by Davalos et al.1 and Zafonte et al.2 showed that citicoline is not efficacious in treating stroke and TBI, respectively, a view that has been echoed by others,3,4 including a recent News & Views article in this journal (Stroke: Treatment for acute stroke—the end of the citicoline saga. Nat. Rev. Neurol.
openaire   +2 more sources

Citicoline versus Rifaximin in Prevention of Recurrence of Hepatic Encephalopathy [PDF]

Afro-Egyptian Journal of Infectious and Endemic Diseases
Background and study aims: Hepatic encephalopathy (HE) is a major neuropsychiatric complication of liver cirrhosis. Recurrent episodes significantly impair quality of life and increase hospitalization and mortality risks.
Mohammed Hussien Ahmed, Hassan Elbatee, Ahmed Amin Ali, Rania Salama, Mohammed Hussien Al Hejab, Aya Mahros   +5 more
doaj   +1 more source

Liposomal Encapsulation of Citicoline for Ocular Drug Delivery

International Journal of Molecular Sciences, 2023
Glaucoma represents a group of neurodegenerative diseases characterized by optic nerve damage and the slowly progressive death of retinal ganglion cells. Glaucoma is considered the second leading cause of irreversible blindness worldwide. Pharmaceutical treatment of glaucoma is critical because of the properties of the ocular barrier that limit the ...
Bonechi, Claudia, Mahdizadeh, Fariba Fahmideh, Talarico, Luigi, Pepi, Simone, Tamasi, Gabriella, Leone, Gemma, Consumi, Marco, Donati, Alessandro, Magnani, Agnese   +8 more
openaire   +4 more sources

Clinical applications of wearable devices for individuals with at‐risk substance use and substance use disorders: A systematic review

The American Journal on Addictions, EarlyView.
Abstract Background and Objectives Managing substance use disorders (SUDs) is limited by the lack of longitudinal clinical data during active use and recovery. Wearable devices may help address this gap by capturing physiological and behavioral data in real‐world settings.
Alexandra Sas, Matthew E. Sloan, Yaoyi Xing, Ethan Kim, Dhvani Mehta, Anna Mouzenian, Lena C. Quilty, Jeffrey D. Wardell, Shannon Lange, Daniel Felsky, Victor M. Tang   +10 more
wiley   +1 more source

Citicoline on the Barthel Index: Severe and moderate brain injury

, 2023
INTRODUCTION: Traumatic brain injury (TBI) is a paramount factor in mortality and morbidity. The clinical trials conducted to investigate the efficacy of neuroprotective agents, such as citicoline, as a therapeutic alternative for TBI have presented ...
Mahmoodkhani, M., Aminmansour, B., Shafiei, M., Hasas, M., Tehrani, D. S.   +4 more
core   +1 more source

Pemberian Citicoline pada Tikus Cedera Saraf Mentalis: Ekspresi Gen SIRT1 Ganglion Trigeminal

Jurnal Farmasi Galenika (Galenika Journal of Pharmacy), 2018
Cedera saraf perifer menyebabkan jumlah neuron menurun di ganglion sensorik, sehingga regenerasinya tidak baik. Pemberian Citicoline telah dilaporkan dapat memperbaiki kondisi fungsi motorik dan mencegah nyeri neuropati pada model tikus cedera saraf ...
David Pakaya, Iniche Tinta, Elfiana Ibrahim, Imtihanah Amri   +3 more
doaj   +1 more source